How Does Bricanyl Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Bricanyl Works
- Active Ingredient: Terbutaline sulfate, a selective beta2‑adrenoceptor agonist.
- Primary Action: Rapidly relaxes bronchial smooth muscle, relieving asthma symptoms within 5–15 minutes.
- Duration: Effects last up to 6 hours; maximum 4 inhalations per 24 hours.
- Metabolism: Mainly metabolised in the liver by sulfation; excreted renally (60%) and in faeces.
- Device: Delivered via Turbohaler® – a dry powder inhaler containing 120 doses.
Bricanyl (terbutaline) is a fast‑acting reliever inhaler that opens the airways by stimulating beta2‑receptors on bronchial muscle. This page explains its chemical structure, mechanism, and how the body processes it.
Important Medical Advice
Stop using Bricanyl and seek immediate medical help if you experience sudden wheezing after inhalation (possible paradoxical bronchospasm), or signs of allergic reaction such as swollen face, skin rash, or collapse. If your asthma worsens or you need more than 4 inhalations in 24 hours, contact your doctor urgently.
Chemical Composition & Molecular Structure
Bricanyl Turbohaler 0.5 mg/dose contains the active substance terbutaline sulfate. Each delivered dose (one inhalation) contains 0.5 mg of terbutaline sulfate. The only excipient is lactose monohydrate (which contains trace milk proteins).
Structural Details
5‑[2‑(tert‑butylamino)‑1‑hydroxyethyl]benzene‑1,3‑diol sulfate (2:1)
A selective beta2‑agonist with a resorcinol ring and a tertiary butyl group that confers beta2 selectivity. The sulfate salt improves stability and solubility.
Key Pharmaceutical Properties
| Property | Terbutaline |
|---|---|
| Lipophilicity (logP) | 0.9 (moderately hydrophilic) |
| Protein binding | 20–25% |
| Oral bioavailability | 15% (extensive first‑pass) |
| Receptor affinity | High beta2‑adrenoceptor selectivity |
🗒️ Pharmaceutical insight: The lactose carrier ensures accurate dose delivery; the Turbohaler device minimises oropharyngeal deposition, optimising lung targeting.
Mechanism of Action: Beta2‑Adrenergic Pathway
Terbutaline is a selective beta2‑adrenoceptor agonist. After inhalation, it binds to beta2‑receptors on airway smooth muscle cells, activating the stimulatory G‑protein (Gs). This increases adenylate cyclase activity, raising intracellular cyclic AMP (cAMP). Elevated cAMP activates protein kinase A (PKA), which phosphorylates multiple targets, leading to:
- Relaxation of bronchial smooth muscle
- Inhibition of mast cell mediator release
- Enhanced mucociliary clearance
| Feature | Terbutaline |
|---|---|
| Onset of action | 5–15 minutes |
| Peak effect | 1–2 hours |
| Duration | Up to 6 hours |
🗒️ Physiological insight: The rapid onset makes Bricanyl suitable for as‑needed relief of acute asthma symptoms.
Absorption & Distribution (Pharmacokinetics)
Following inhalation, approximately 30–40% of the delivered dose reaches the lungs; the remainder is deposited in the oropharynx and swallowed.
Pulmonary absorption
Terbutaline is absorbed rapidly from the lungs into systemic circulation. Peak plasma concentrations occur within 30–60 minutes.
Distribution
The volume of distribution is about 1.5 L/kg. Terbutaline crosses the placenta and appears in breast milk in small amounts.
Metabolic Effects & Elimination
Terbutaline is metabolised primarily in the liver by sulfation (major pathway) and to a lesser extent by glucuronidation. Cytochrome P450 enzymes play a minimal role. The main metabolite is the sulfate conjugate, which is inactive.
Excretion is predominantly renal: about 60% of a dose appears in urine as unchanged drug and metabolites. The remainder is eliminated via bile in faeces. The elimination half‑life is 3–4 hours.
⚠️ Metabolic caution: Severe hepatic impairment may slightly reduce clearance, but dose adjustment is not usually required. Monitor potassium levels as terbutaline can cause hypokalaemia.
Clinical Efficacy in Asthma Management
Bricanyl is indicated for the relief of bronchospasm in asthma and other reversible airways obstruction. In clinical use, it improves FEV₁ within minutes and reduces symptoms of wheeze, cough, and breathlessness. It is used on an as‑required basis, not for regular maintenance. The maximum recommended dose is 4 inhalations in 24 hours. If a patient requires more frequent use, asthma control should be reviewed and anti‑inflammatory therapy (e.g., inhaled corticosteroid) optimised.
The SMART studies have not included Bricanyl as a reliever in combination maintenance therapy; it remains a standalone reliever.
Bricanyl FAQs
How long does it take for Bricanyl to start working?
Bricanyl usually begins to relieve symptoms within 5–15 minutes after inhalation, with peak effect at 1–2 hours. The effect lasts up to 6 hours.
Can I use Bricanyl every day?
Bricanyl is intended for as‑needed relief, not regular daily use. If you need it more than twice a week, your asthma may be poorly controlled – consult your doctor to review treatment.
What are the common side effects of Bricanyl?
Very common side effects include trembling (especially in the hands) and headache. Common effects are palpitations, muscle cramps, and low potassium. These are usually mild and transient.
Is Bricanyl safe for children?
Yes, Bricanyl Turbohaler can be used in children under medical supervision. The dose is the same (one inhalation as required), but ensure the child can use the inhaler correctly. Maximum 4 inhalations per 24 hours.
Can I use Bricanyl if I am pregnant or breastfeeding?
Use only if clearly needed and prescribed by your doctor. Uncontrolled asthma poses greater risks. Terbutaline passes into breast milk in small amounts but is considered compatible with breastfeeding.
Need Bricanyl with Expert Guidance?
If you have asthma and think a reliever like Bricanyl may be appropriate, a UK‑registered doctor can assess your symptoms and provide a prescription online.
Secure Prescription & Next-Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Asthma ConsultationRelated Bricanyl Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 09 March 2026
Next Review: 09 September 2026
Published on: 09 March 2026
Last Updated: 09 March 2026